Webinar: EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development
According to recent scientific advancements, mRNA technology has revolutionized the field of vaccine development, particularly in combating infectious diseases like COVID-19. mRNA vaccines work by instructing cells to produce a protein that triggers an immune response, effectively training the body to recognize and combat the virus. This innovative approach offers faster production times and adaptability to emerging variants, making it a critical tool in modern medicine’s arsenal against pandemics.
Creative Biolabs has invited Dr. Magnus A.G. Hoffmann to walk us through the application of hybrid mRNA technology in vaccine development, strategies for optimizing hybrid mRNA vaccines, and the use of this technology in developing pan-coronavirus vaccines.
Additional Details
Other core Themes -
Online or Hybrid event - No
Number of participants - 13
Attachments -
Organizer
The conjugation of cytotoxic agents to antibodies via specific linkers is a delicate process, ensuring that the drug only becomes active upon reaching the cancer cell. This precise delivery limits off-target effects.